TerrAscend Corp. Stock Losses? | Goodman & Nekvasil, P.A.
TerrAscend Corp. Stock Losses?
TerrAscend Corp. Stock Losses?
Call 800-500-4442 if you think that you have received unsuitable investment recommendations from your adviser.
TerrAscend Corp. and the Risks of OTC Stocks. Goodman & Nekvasil, P.A. is speaking to customers of a broker who recommended the sale of TerrAscend Corp. A FINRA arbitration claim is pending for a customer who allegedly purchased CANNIBAS SECURITIES from this Morgan Stanley Broker.
TerrAscend is a cannabis operator with vertically integrated operations in California, Michigan, New Jersey, and Pennsylvania, licensed cultivation and processing operations in Maryland, and licensed production in Canada. TerrAscend is listed on the Canadian Securities Exchange under the ticker symbol “TER:CNX” and on the OTC Markets under the ticker symbol “TRSSF.” In January 2023, according to The Wall Street Journal, TerrAscend had a market capitalization of $398.6 million, and its shares were trading at a value of $1.38 per share on the OTC Markets.
Many investors are not fully aware of the problems and risks associated with high risk, alternative investments when they purchase them.
Investments in over the counter stock offerings are often riskier and more complicated than traditional investments. These funds are only suitable for high net worth, sophisticated investors.
Liquidity Issues and High Sales Commissions
Thinly traded stocks can face several liquidity issues due to their unique characteristics and structure.
Another problem often associated with alternative investments is the high sales commissions brokers typically earn for selling them. Brokers have an obligation to make investment recommendations that are consistent with their clients risk tolerance, net worth, investment objectives and experience in the market.
Unfortunately, in many cases, the high sales commission may influence unsuitable investment recommendations.
Broker Due Diligence
Broker dealers are required to perform adequate due diligence on any investment they recommend and to ensure that all recommendations are suitable for the investor. Firms that fail to do so may be held responsible for any losses in a FINRA arbitration claim.
If you believe that your investments in TerrAscend Corp. may have been unsuitable or otherwise improper for you, we would like to discuss the possibility of your retaining our firm to represent you in an arbitration action.
There is no charge for an evaluation of your case. We handle our cases on a contingency fee basis. If we don’t recover money for you, we charge no attorney’s fee.
Goodman & Nekvasil, P.A. has recovered more than $400 million on behalf of victimized investors. If you lost money on investments in unsuitable investments and would like your case evaluated by a securities attorney, please contact us.
Some of the information in this blog post was obtained from the SEC and FINRA on 11/12/24. If you believe this information was reported incorrectly, please contact our firm: 1-800-500-4442